Inflammatory Bowel Disease

Six months of combined impact and resistance training improved bone mineral density and muscle function in adults with Crohn’s disease, according to study results.

Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease was safe and well tolerated and resulted in a high rate of C. difficile decolonization, according to a study published in Gastroenterology.

Individuals with atopic diseases such as asthma and atopic dermatitis appeared to be at higher risk for developing inflammatory bowel disease, according to study results.

After dysplasia resection in patients with inflammatory bowel disease, risk for colorectal cancer was low, according to results published in Gastrointestinal Endoscopy.

Patients with inflammatory bowel disease who received home infusions of Remicade had higher rates of nonadherence and discontinuation of the drug, according to study results.

Both patients and gastroenterologists have reported being highly satisfied with telehealth services amid COVID-19, according to results from a recent study. It was the top story in gastroenterology last week.

Investigators found a low incidence of SARs-CoV-2 among patients with inflammatory bowel disease who were taking biologic therapy, according to recently published data in the Journal of Gastroenterology and Hepatology.

As far as hot-button health care topics go, it is hard to top vaccines. Even dropped into a casual conversation, the idea itself in its various iterations can cause tension and divisiveness.

Entyvio yielded a lower risk for non-infectious serious adverse events than TNF antagonist therapy in Crohn’s disease, according to a study published in Alimentary Pharmacology and Therapeutics.

Clinicians who manage patients with immune-mediated diseases can offer useful insight into the management of COVID-19, according to presenters at a roundtable discussion at the 2020 Interdisciplinary Autoimmune Summit.